Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0890
+0.0040 (4.71%)
Jul 14, 2026, 1:10 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 27.34 million as of July 14, 2026. Its market cap has increased by 24.76% in one year.
Market Cap
27.34M
Enterprise Value
31.50M
Revenue
3.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 27.34M, an increase of 96.63%. That is a compound annual growth rate of 7.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 27.34M | 0.61% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 56.05M |
| Neurizon Therapeutics | 50.00M |
| Imugene | 43.66M |
| Proteomics International Laboratories | 33.86M |
| Patrys | 26.66M |
| Algorae Pharmaceuticals | 26.33M |
| Neurotech International | 22.40M |
| NeuroScientific Biopharmaceuticals | 21.62M |